Study Summary
This trial aims to reduce risk of type 2 diabetes in people with pre-diabetes by increasing access to lifestyle interventions. We will also study changes in body fat & liver fat in those who complete the program.
- Diabetes
- Prediabetes
- Fatty Liver Disease
- Weight Changes
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
2 Primary · 3 Secondary · Reporting Duration: end of calendar year enrollment, yearly for 3 years
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Intervention
1 of 1
Experimental Treatment
20000 Total Participants · 1 Treatment Group
Primary Treatment: Intervention · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 89 · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are individuals aged 35 or older being admitted to this investigation?
"This clinical trial is recruiting participants that are of legal age or above and have not reached their 89th year." - Anonymous Online Contributor
Do I qualify to take part in this research?
"This clinical trial seeks to involve 20,000 individuals with fatty liver disease between the ages of 18 and 89. The most essential inclusion criterion is that patients must have type 2 diabetes for DSMT (Diabetes Self-Management Training)." - Anonymous Online Contributor
Are participants still being accepted into this clinical investigation?
"According to the data on clinicaltrials.gov, this investigation is not looking for additional participants at present. The study was first released in April 1st 2023 and updated lastly on March 2nd 2023. Although it is not recruiting presently, there are 1762 other medical trials actively searching for patients right now." - Anonymous Online Contributor